Capital/Financing Update • Apr 8, 2014
Capital/Financing Update
Open in ViewerOpens in native device viewer

| Date of Announcement | 8 April2014 |
|---|---|
| Reference | 98/2014 |
The following is a company announcement issued by Medserv p.l.c. (the "Company") pursuant to Chapter 5 of the Listing Rules.
Reference is made to the €20,000,000 Secured and Guaranteed Debt Issuance Programme approved by the Listing Authority for the admissibility to listing on the Official List of the Malta Stock Exchange (the "Programme") (Company Announcements MDS [79] and MDS [80]).
On the 7 April 2014, the Listing Authority approved a Supplement (the "Second Supplement") to the Prospectus dated 12 August 2013, as supplemented by a Supplement dated 30 August 2013. Copies of the Prospectus, as supplemented by a Supplement dated 30 August 2013 and the Second Supplement dated 7 April 2014 can be downloaded from the websites of:
with effect from 9 April 2014.
As from the 16 April 2014, the Prospectus, as supplemented, can also be obtained during office hours from the registered office of the Company.
Furthermore, the Company announces that, pursuant to the Programme, Final Terms dated 7 April 2014 and offering the second and final tranche of the first and final series under the Programme (the "Final Terms") will be published on the 9 April 2014. The Notes being offered are €7,000,000 6% Secured and Guaranteed Notes due 2023 (with the Company's option to redeem from the year 2020). A copy of the Final Terms will also be available on the above mentioned websites.


The Notes which are of a nominal value of €100, will be offered at a price of €101.50. The Company entered into a conditional subscription agreement with Rizzo, Farrugia & Co (Stockbrokers) Ltd, Airways House, Third Floor, High Street, Sliema SLM 1549 and HSBC Bank Malta p.l.c. 116, Archbishop Street, Valletta VLT 1444 respectively on 7 April 2014, whereby the Company bound itself to allocate to Rizzo, Farrugia & Co (Stockbrokers) Ltd. (€4,000,000) and HSBC Bank Malta p.l.c. (€3,000,000), which have bound themselves to purchase, the Notes amounting to an aggregate value of €7,000,000 on 29 April 2014.
For further details on the Programme, the said Notes and the Company, investors are to consult the Prospectus as supplemented by a Supplement dated 30 August 2013 and the Supplement dated 7 April 2014, and the Final Terms.
UNQUOTE
Signed:
__________________
Louis de Gabriele Company Secretary
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.